Centogene (NASDAQ:CNTG) Short Interest Up 5.3% in March

Centogene (NASDAQ:CNTGGet Free Report) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 11,900 shares, an increase of 5.3% from the March 15th total of 11,300 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 44,800 shares, the days-to-cover ratio is currently 0.3 days.

Centogene Stock Performance

Shares of NASDAQ:CNTG opened at $0.48 on Wednesday. Centogene has a 52 week low of $0.46 and a 52 week high of $2.52. The firm has a 50 day simple moving average of $0.75 and a 200 day simple moving average of $1.02.

Centogene Company Profile

(Get Free Report)

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.

Featured Stories

Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.